Affiliation:
1. Institute of Biomedical and Life Sciences, Division of Infection and Immunity, Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, United Kingdom
Abstract
ABSTRACT
Nucleobase and nucleoside transporters play central roles in the biochemistry of parasitic protozoa, as they lack the ability to synthesize purines de novo and are absolutely reliant upon purine salvage from their hosts. Furthermore, such transporters are potentially critical to the pharmacology of these important human pathogens, because they mediate the uptake of purine analogues, as well as some nonpurine drugs, that can be selectively cytotoxic to the parasites. We here report the first identification and characterization of a purine nucleobase transporter in
Leishmania
amastigotes. Uptake of [
3
H]hypoxanthine by
Leishmania mexicana
amastigotes was mediated by a single high-affinity transporter, LmexNBT1, with a
K
m
of 1.6 ± 0.4 μM and high affinity for adenine, guanine, and xanthine but low affinity for nucleosides and pyrimidine nucleobases. Allopurinol, an antileishmanial hypoxanthine analogue, was apparently taken up by the same transporter. Using [
3
H]allopurinol, a
K
m
value of 33.6 ± 6.0 μM was obtained. All evidence was compatible with a model of a single purine nucleobase transporter being expressed in amastigotes. Using various purine nucleobase analogues, a model for the interactions between hypoxanthine and the transporter's permeant binding site was constructed. The binding interactions were compared with those of the LmajNBT1 transporter in
Leishmania major
promastigotes and found to be very similar.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference60 articles.
1. Abrishami, M., M. Soheilian, A. Farahi, and Y. Dowlati. 2002. Successful treatment of ocular leishmaniasis. Eur. J. Dermatol.12:88-89.
2. Al Salabi, M. I., L. J. Wallace, and H. P. de Koning. 2003. A Leishmania major nucleobase transporter responsible for allopurinol uptake is a functional homolog of the Trypanosoma brucei H2 transporter. Mol. Pharmacol.63:814-820.
3. Avila, J. L., A. Avila, E. Munoz, and H. Monzon. 1983. Trypanosoma cruzi: 4-aminopyrazolopyrimidine in the treatment of experimental Chagas' disease. Exp. Parasitol.56:236-240.
4. Comparative effects of 4-aminopyrazolopyrimidine, its 2'-deoxyriboside derivative, and allopurinol on in vitro growth of American Leishmania species
5. Berens, R. L., E. C. Krug, and J. J. Marr. 1995. Purine and pyrimidine metabolism, p. 89-117. In J. J. Marr and M. Muller (ed.), Biochemistry and molecular biology of parasites. Harcourt Brace & Company, London, United Kingdom.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献